NCT02492386View on ClinicalTrials.gov

Bioabsorbable Everolimus-Eluting Stents for Internal Pudendal Artery-Related Arteriogenic Erectile Dysfunction

PHASE2/PHASE3UnknownINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

September 30, 2016

Study Completion Date

March 31, 2017

Conditions
Impotence, Arteriogenic
Interventions
DEVICE

Bioabsorbable everolimus-eluting stent deployment

Bioabsorbable everolimus-eluting stent deployment

Sponsors

Collaborators (1)

Abbott
All Listed Sponsors
collaborator

Abbott

INDUSTRY

lead

National Taiwan University Hospital

OTHER

NCT02492386 - Bioabsorbable Everolimus-Eluting Stents for Internal Pudendal Artery-Related Arteriogenic Erectile Dysfunction | Biotech Hunter | Biotech Hunter